| Product Code: ETC7655326 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Malaria Vaccine Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Malaria Vaccine Market - Industry Life Cycle |
3.4 Israel Malaria Vaccine Market - Porter's Five Forces |
3.5 Israel Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 Israel Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increased government initiatives and funding for malaria prevention and eradication programs |
4.2.2 Growing awareness about the importance of vaccination and preventive healthcare measures |
4.2.3 Rising incidence of malaria cases in Israel and neighboring regions |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for vaccine approval and distribution |
4.3.2 Limited access to healthcare services in remote areas where malaria is prevalent |
4.3.3 Potential resistance to vaccination among certain population segments |
5 Israel Malaria Vaccine Market Trends |
6 Israel Malaria Vaccine Market, By Types |
6.1 Israel Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 Israel Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 Israel Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 Israel Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 Israel Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 Israel Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 Israel Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 Israel Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 Israel Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 Israel Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 Israel Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 Israel Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 Israel Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 Israel Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Israel Malaria Vaccine Market Import-Export Trade Statistics |
7.1 Israel Malaria Vaccine Market Export to Major Countries |
7.2 Israel Malaria Vaccine Market Imports from Major Countries |
8 Israel Malaria Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage in high-risk regions |
8.2 Number of research and development collaborations for malaria vaccine development |
8.3 Rate of decline in malaria cases in Israel and neighboring regions due to vaccination efforts |
9 Israel Malaria Vaccine Market - Opportunity Assessment |
9.1 Israel Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 Israel Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Malaria Vaccine Market - Competitive Landscape |
10.1 Israel Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Israel Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here